What is the ticker symbol for Lineage Cell Therapeutics, Inc.?

The ticker symbol for Lineage Cell Therapeutics, Inc. is NYSEAmerican:LCTX

Does Lineage Cell Therapeutics, Inc. pay dividends?

No, Lineage Cell Therapeutics, Inc. does not pay dividends

What sector is Lineage Cell Therapeutics, Inc. in?

Lineage Cell Therapeutics, Inc. is in the Healthcare sector

What industry is Lineage Cell Therapeutics, Inc. in?

Lineage Cell Therapeutics, Inc. is in the Biotechnology industry

What country is Lineage Cell Therapeutics, Inc. based in?

Lineage Cell Therapeutics, Inc. is headquartered in United States

When did Lineage Cell Therapeutics, Inc. go public?

Lineage Cell Therapeutics, Inc. initial public offering (IPO) was on March 5, 1992

Is Lineage Cell Therapeutics, Inc. in the S&P 500?

No, Lineage Cell Therapeutics, Inc. is not included in the S&P 500 index

Is Lineage Cell Therapeutics, Inc. in the NASDAQ 100?

No, Lineage Cell Therapeutics, Inc. is not included in the NASDAQ 100 index

Is Lineage Cell Therapeutics, Inc. in the Dow Jones?

No, Lineage Cell Therapeutics, Inc. is not included in the Dow Jones index

When was Lineage Cell Therapeutics, Inc. last earnings report?

Lineage Cell Therapeutics, Inc.'s most recent earnings report was on August 6, 2026

When does Lineage Cell Therapeutics, Inc. report earnings?

The next expected earnings date for Lineage Cell Therapeutics, Inc. is November 5, 2026

LCTX Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, LCTX price is $0.98, down -4.97% in the most recent trading session on September 28, 2026
Current Price All-Time High: LCTX price is currently -96.37% below its historical high of $27.00 set on October 31, 1997
Market Cap: LCTX current market cap is $248M, down -36.61% year-over-year
Revenue: LCTX current annual revenue is $14.56M, up +53.24% year-over-year
Next Earnings: The next earnings release for LCTX is on November 5, 2026

Profile

Company profile for Lineage Cell Therapeutics, Inc. (LCTX)
Metric	Value
Full Name	Lineage Cell Therapeutics, Inc.
Ticker	NYSEAmerican: LCTX
Exchange	NYSE American
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Mar 5, 1992
Indexes	Not included
Website	lineagecell.com
Employees	70

Key Metrics

Lineage Cell Therapeutics, Inc. Key Details
Metric	Value	Date
	$0.98	Sep 28, 26
Price, 1D Change	-4.97%	Sep 28, 26
	$248M	Sep 28, 26
	-	Sep 28, 26
	-	Sep 28, 26
	1.37	Sep 25, 26
	$14.56M	Dec 31, 25
Revenue, 1Y Change	+53.24%	Dec 31, 25
	-$0.28	Dec 31, 25
EPS, 1Y Change	-196.88%	Dec 31, 25

Events

Lineage Cell Therapeutics, Inc. Events
Metric	Value	Date
Next Earnings		Nov 5, 26
Last Qtr. Earnings		Aug 6, 26
Last Ann. Earnings		Mar 5, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	3:1	Oct 31, 97
Next Split	N/A	N/A
Last Ticker Change	BTX	Aug 12, 19
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

LCTX Estimates
Metric	Value	Date
	-$0.28	Dec 31, 25
EPS Estimate	-$0.07	N/A
EPS Est. Change	+76.46%	N/A
	$14.56M	Dec 31, 25
Revenue Estimate	$15.19M	N/A
Revenue Est. Change	+4.38%	N/A
	$0.98	Sep 28, 26
Price Target	$4.50	-
Price Tgt. Change	+359.75%	-

🔒 Log In To Unlock Full Data

EPS

LCTX EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$0.11	-$0.09	+15.45%
2025	-$0.29	-$0.28	+4.23%
2026	-$0.07	N/A	+76.46%
2027	-$0.14	N/A	+50.20%

Revenue

LCTX revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$8.25M	$9.50M	+15.09%
2025	$9.90M	$14.56M	+47.01%
2026	$15.19M	N/A	+4.38%
2027	$16.83M	N/A	+15.65%

🔒 Log In To Unlock Full Data

Performance

LCTX Performance
Metric	Value	Date
	-42.76%	Sep 28, 26
	-16.34%	Sep 28, 26
	-36.61%	Sep 28, 26
	+21.29%	Sep 28, 26
	+53.24%	Dec 31, 25
	-1.00%	Dec 31, 25
	-196.88%	Dec 31, 25
	-78.47%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

LCTX Technical Indicators
Metric	Value	Date
	$0.98	Sep 28, 26
	$1.42	Sep 25, 26
	$1.08	Sep 25, 26
	$1.28	Sep 25, 26
	$1.10	Sep 25, 26
	-$0.03	Sep 25, 26
	1.37	Sep 25, 26
	$0.06	Sep 25, 26
	46.67	Sep 25, 26
	73.68%	Sep 25, 26

Dividends

LCTX Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 28, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

LCTX Income & Profitability
Metric	Value	Date
	$14.56M	Dec 31, 25
	-$0.28	Dec 31, 25
	$13.71M	Dec 31, 25
	94.19%	Dec 31, 25
	-$21.78M	Dec 31, 25
	-149.62%	Dec 31, 25
	-$63.37M	Dec 31, 25
	-435.33%	Dec 31, 25
	-$21.08M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

LCTX Financial Health
Metric	Value	Date
	0.05	Dec 31, 25
	5.20	Dec 31, 25
	5.20	Dec 31, 25
	-	Dec 31, 25
	3	Jun 30, 26
	-3.66	Sep 28, 26

Valuations

LCTX Valuations
Metric	Value	Date
	-	Sep 28, 26
	18.92	Sep 28, 26
	4.06	Sep 28, 26
	-7.62	Sep 28, 26
	-	N/A

Balance Sheet

LCTX Balance Sheet
Metric	Value	Date
	$44.55M	Dec 31, 25
	$55.78M	Dec 31, 25
	$112.58M	Dec 31, 25
	$59.16M	Dec 31, 25
	$69.24M	Dec 31, 25
	$11.37M	Dec 31, 25
	$2.42M	Dec 31, 25
	$853.00K	Dec 31, 25
	$2.34M	Dec 31, 25

Expenses

LCTX Expenses
Metric	Value	Date
	$78.09M	Dec 31, 25
	$35.49M	Dec 31, 25
	$845.00K	Dec 31, 25
	$0.00	Dec 31, 25
	$699.00K	Dec 31, 25
	$0.00	Dec 31, 25
	-$5.28M	Dec 31, 25

Cash Flow

LCTX Cash Flow
Metric	Value	Date
	-$18.92M	Dec 31, 25
	-$13.46M	Dec 31, 25
	$26.95M	Dec 31, 25
	$522.00K	Dec 31, 25
	-$19.44M	Dec 31, 25

Recent analyst updates

LCTX Recent analyst updates
Metric	Value	Date
HC Wainwright & Co.	→	Jul 14, 26
D. Boral Capital	→	May 4, 26
Canaccord Genuity		Apr 28, 26
B. Riley Securities	→	Mar 25, 26
HC Wainwright & Co.	→	Mar 24, 26
D. Boral Capital	→	Mar 6, 26
D. Boral Capital	→	Feb 9, 26
D. Boral Capital	→	Nov 25, 25
HC Wainwright & Co.	→	Nov 24, 25
D. Boral Capital	→	Aug 27, 25

Analyst sentiment

Institutional ownership

Screeners with LCTX

OtherSentiment

OtherMarket cap

Small Cap Stocks

OtherTypes

All Stocks

OtherExchanges

NYSE American Exchange Companies

CountriesOther

US Stocks

Sectors & IndustriesAll Sectors

Healthcare Sector

Sectors & IndustriesAll Industries

Biotech Companies

FAQ

What is the ticker symbol for Lineage Cell Therapeutics, Inc.?: The ticker symbol for Lineage Cell Therapeutics, Inc. is NYSEAmerican:LCTX
Does Lineage Cell Therapeutics, Inc. pay dividends?: No, Lineage Cell Therapeutics, Inc. does not pay dividends
What sector is Lineage Cell Therapeutics, Inc. in?: Lineage Cell Therapeutics, Inc. is in the Healthcare sector
What industry is Lineage Cell Therapeutics, Inc. in?: Lineage Cell Therapeutics, Inc. is in the Biotechnology industry
What country is Lineage Cell Therapeutics, Inc. based in?: Lineage Cell Therapeutics, Inc. is headquartered in United States
When did Lineage Cell Therapeutics, Inc. go public?: Lineage Cell Therapeutics, Inc. initial public offering (IPO) was on March 5, 1992
Is Lineage Cell Therapeutics, Inc. in the S&P 500?: No, Lineage Cell Therapeutics, Inc. is not included in the S&P 500 index
Is Lineage Cell Therapeutics, Inc. in the NASDAQ 100?: No, Lineage Cell Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Lineage Cell Therapeutics, Inc. in the Dow Jones?: No, Lineage Cell Therapeutics, Inc. is not included in the Dow Jones index
When was Lineage Cell Therapeutics, Inc. last earnings report?: Lineage Cell Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
When does Lineage Cell Therapeutics, Inc. report earnings?: The next expected earnings date for Lineage Cell Therapeutics, Inc. is November 5, 2026

Data Sources & References

LCTX Official Website www.lineagecell.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/876343/000119312526093992/0001193125-26-093992-index.htm
LCTX Profile on Yahoo Finance finance.yahoo.com/quote/LCTX
LCTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lctx